UPDATE: Here are the best S&P 500 stocks and sectors of 2014
InSite Vision Announces Date for Annual Stockholder Meeting
Research and Markets: Acne Vulgaris - Pipeline Review, H2 2014
Research and Markets: Acne Vulgaris - Pipeline Review, H1 2014
COTCHETT, PITRE & McCARTHY, LLP Files Class Action Lawsuit on Behalf of Persons Who Sold Allergan Stock Between February 25, 2014 and April 21, 2014
Brent Saunders faces challenge of running combined Actavis-Allergan
Valeant Announces Redemption of US$445.0 Million Aggregate Principal Amount of its Outstanding 6.875% Senior Notes due 2018
Activist Fund ValueAct Capital to Seek Up to $1.5 Billion From Investors -- Update
Our Ultimate Stock-Pickers Index continues to beat the market even as relatively few of our top managers are outperforming the S&P 500.
This article represents opinions of the author and not those of his firm and are subject to change from time to time and do not constitute a recommendation to purchase and sale any security nor to engage in any particular investment strategy. The information contained here has been obtained from ...